glp-1 drugs and lupus The anti-inflammatory immunological properties of Receptor Agonists GLP-1 RA Drugs Benefit People
Description
Mechanisms and clinical efficacy of lixisenatide for the management of type 2 diabetes
As GLP-1RAs become more commonly used, clinicians need to monitor for AV dermatological side effects while planning suitable treatment approaches for patients who develop this condition
without type 2 diabetes used glucagon-like peptide-1 (GLP-1) medication to help manage obesity
However, some patients report the opposite effect
and internationally
Indicators of high risk include being 55 years of age or older with coronary, carotid, or lower extremity artery stenosis of more than 50% or with left ventricular hypertrophy
